Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.

Journal article

EMPA-KIDNEY Collaborative Group None. et al, (2024), N Engl J Med

Effect of Fenofibrate on Progression of Diabetic Retinopathy.

Journal article

Preiss D. et al, (2024), NEJM evidence, EVIDoa2400179 - EVIDoa2400179

Empagliflozin in Patients with Chronic Kidney Disease

Journal article

HERRINGTON W. et al, (2022), New England Journal of Medicine

Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.

Journal article

HPS3/TIMI55-REVEAL Collaborative Group None. et al, (2022), Eur Heart J, 43, 1416 - 1424

Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial

Journal article

HERRINGTON W., (2022), Nephrology, Dialysis and Transplantation

Load More